127 related articles for article (PubMed ID: 37718231)
21. Peritoneal carcinomatosis index and overall survival in patients taken to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
López-Basave HN; Morales-Vázquez F; Herrera-Gómez Á; Miranda-Devora G; Padilla-Rosciano AE; Castillo-Morales C; Paleta-Torres CA; Vázquez-Cortes E
Cir Cir; 2023; 91(2):195-199. PubMed ID: 37084306
[TBL] [Abstract][Full Text] [Related]
22. The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer.
Rawert FL; Luengas-Würzinger V; Claßen-Gräfin von Spee S; Baransi S; Schuler E; Carrizo K; Dizdar A; Mallmann P; Lampe B
Arch Gynecol Obstet; 2022 Nov; 306(5):1665-1672. PubMed ID: 35357582
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer.
Lei Z; Wang Y; Wang J; Wang K; Tian J; Zhao Y; Chen L; Wang J; Luo J; Jia M; Tang H; He Q; Liao Q; Yang X; Guan T; Wang L; Cui S;
JAMA Netw Open; 2020 Aug; 3(8):e2013940. PubMed ID: 32840622
[TBL] [Abstract][Full Text] [Related]
24. Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer.
Mikkelsen MS; Petersen LK; Blaakaer J; Marinovskij E; Rosenkilde M; Andersen G; Bouchelouche K; Iversen LH
Eur J Surg Oncol; 2021 Aug; 47(8):2134-2141. PubMed ID: 33812768
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of peritoneal cancer index in primary advanced ovarian cancer.
Llueca A; Escrig J;
Eur J Surg Oncol; 2018 Jan; 44(1):163-169. PubMed ID: 29198495
[TBL] [Abstract][Full Text] [Related]
26. MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients.
Engbersen MP; Van' T Sant I; Lok C; Lambregts DMJ; Sonke GS; Beets-Tan RGH; van Driel WJ; Lahaye MJ
Eur J Radiol; 2019 May; 114():146-151. PubMed ID: 31005166
[TBL] [Abstract][Full Text] [Related]
27. Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study.
Elzarkaa AA; Shaalan W; Elemam D; Mansour H; Melis M; Malik E; Soliman AA
J Gynecol Oncol; 2018 Jul; 29(4):e47. PubMed ID: 29770618
[TBL] [Abstract][Full Text] [Related]
28. Peroperative extent of peritoneal metastases affects the surgical outcome and survival in advanced ovarian cancer.
van Stein RM; Engbersen MP; Stolk T; Lopez-Yurda M; Lahaye MJ; Beets-Tan RGH; Lok CAR; Sonke GS; Van Driel WJ
Gynecol Oncol; 2022 Nov; 167(2):269-276. PubMed ID: 36088169
[TBL] [Abstract][Full Text] [Related]
29. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S
Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648
[TBL] [Abstract][Full Text] [Related]
30. Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival.
Avesani G; Arshad M; Lu H; Fotopoulou C; Cannone F; Melotti R; Aboagye E; Rockall A
Radiol Med; 2020 Aug; 125(8):770-776. PubMed ID: 32239470
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.
Angeles MA; Ferron G; Cabarrou B; Balague G; Martínez-Gómez C; Gladieff L; Pomel C; Martinez A
Eur J Surg Oncol; 2019 Aug; 45(8):1410-1416. PubMed ID: 30857876
[TBL] [Abstract][Full Text] [Related]
32. Oncologic outcomes in patients undergoing maximal or optimal cytoreductive surgery for Stage 3C serous ovarian, tubal or peritoneal carcinomas.
Gurkan D; Ceren Akin A; Sahin H; Aytac Tohma Y; Sahin EA; Gunakan E; Iflazoglu N; Nihan Haberal A; Ayhan A
J Obstet Gynaecol; 2020 May; 40(4):551-557. PubMed ID: 31482736
[TBL] [Abstract][Full Text] [Related]
33. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
[TBL] [Abstract][Full Text] [Related]
34. Is complete cytoreductive surgery feasible in this patient with ovarian cancer?
Dessapt AL; Huchon C; Ngo C; Bats AS; Bensaid C; Lecuru F
Surg Oncol; 2016 Sep; 25(3):326-31. PubMed ID: 27566040
[TBL] [Abstract][Full Text] [Related]
35. Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective international multicentric data analysis.
Torun BC; Glehen O; Kepenekian V; Sardi A; Arjona-Sanchez A; Yonemura Y; Barat S; Morris D; Spiliotis J; Coccolini F; Sommariva A; Bartos A; Raza S; Speteen KV; Akin L; Irez T; Canbay E;
Eur J Surg Oncol; 2023 Aug; 49(8):1489-1494. PubMed ID: 37085403
[TBL] [Abstract][Full Text] [Related]
36. A Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy in Primary Advanced Ovarian Cancer: The First Reported Pilot Experience from Saudi Arabia.
Abu-Zaid A; Alomar O; Alsabban M; Salem H; Al-Badawi IA
Gulf J Oncolog; 2020 Sep; 1(34):19-25. PubMed ID: 33431358
[TBL] [Abstract][Full Text] [Related]
37. Surgical cytoreduction for recurrent epithelial ovarian cancer.
Al Rawahi T; Lopes AD; Bristow RE; Bryant A; Elattar A; Chattopadhyay S; Galaal K
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD008765. PubMed ID: 23450588
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Factors in Patients Undergoing Primary Cytoreductive Surgery for FIGO Stage IIIC Ovarian, Tubal or Peritoneal Cancer.
Kaban A; Topuz S; Saip P; Sözen H; Salihoğlu Y
J Obstet Gynaecol Can; 2018 Apr; 40(4):447-453. PubMed ID: 29055648
[TBL] [Abstract][Full Text] [Related]
39. Tumor Load Matters - the Peritoneal Cancer Index in Patients With High-grade Serous Ovarian Cancer.
Egger E; Merker F; Ralser DJ; Condic M; Marinova M; Muders M; Stope M; Mustea A
Anticancer Res; 2022 Oct; 42(10):4825-4831. PubMed ID: 36192015
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of the immuno-peritoneal cancer index in peritoneal metastatic patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Yildirim Y; Sokmen S; Cevlik AD; Bisgin T; Manoglu B; Obuz F
Langenbecks Arch Surg; 2023 May; 408(1):182. PubMed ID: 37148400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]